A multifunctional heterogeneous-nuclear ribonucleoprotein that may play a role in homologous DNA pairing and recombination. The N-terminal portion of protein is a potent transcriptional activator, while the C terminus is required for RNA binding. The name FUS refers to the fact that genetic recombination events result in fusion oncogene proteins (ONCOGENE PROTEINS, FUSION) that contain the N-terminal region of this protein. These fusion proteins have been found in myxoid liposarcoma (LIPOSARCOMA, MYXOID) and acute myeloid leukemia.
Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.
A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Complexes of RNA-binding proteins with ribonucleic acids (RNA).
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
A family of ribonucleoproteins that were originally found as proteins bound to nascent RNA transcripts in the form of ribonucleoprotein particles. Although considered ribonucleoproteins they are primarily classified by their protein component. They are involved in a variety of processes such as packaging of RNA and RNA TRANSPORT within the nucleus. A subset of heterogeneous-nuclear ribonucleoproteins are involved in additional functions such as nucleocytoplasmic transport (ACTIVE TRANSPORT, CELL NUCLEUS) of RNA and mRNA stability in the CYTOPLASM.
Proteins that bind to the 3' polyadenylated region of MRNA. When complexed with RNA the proteins serve an array of functions such as stabilizing the 3' end of RNA, promoting poly(A) synthesis and stimulating mRNA translation.
Ribonucleic acid that makes up the genetic material of viruses.
A family of RNA-binding proteins that are homologues of ELAV protein, Drosophila. They were initially identified in humans as the targets of autoantibodies in patients with PARANEOPLASTIC ENCEPHALOMYELITIS. They are thought to regulate GENE EXPRESSION at the post-transcriptional level.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
The extent to which an RNA molecule retains its structural integrity and resists degradation by RNASE, and base-catalyzed HYDROLYSIS, under changing in vivo or in vitro conditions.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.
RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.
A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE).
The parts of a macromolecule that directly participate in its specific combination with another molecule.
A family of double-stranded RNA-binding proteins that are related to NFATC TRANSCRIPTION FACTORS. In addition to binding to RNA, nuclear factor 90 proteins form heterodimeric complexes that regulate GENETIC TRANSCRIPTION and may play a role in T-CELL activation.
Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein.

Induction of a secreted protein by the myxoid liposarcoma oncogene. (1/224)

The TLS-CHOP oncoprotein, found in the majority of human myxoid liposarcomas, consists of a fusion between the transcription factor CHOP/GADD153 and the N terminus of an RNA-binding protein TLS/FUS. Clinical correlation and in vitro transformation assays indicate that the N terminus of TLS plays an important role in oncogenesis by TLS-CHOP. Until now, however, the only activity attributed to the oncoprotein is that of inhibiting the binding of transcription factors of the C/EBP class to certain adipogenic target genes, a function that TLS-CHOP shares with the nononcogenic CHOP protein. Here we report the isolation of a gene, DOL54, that is activated in primary fibroblasts by the expression of TLS-CHOP. DOL54 is expressed in the neoplastic component of human myxoid liposarcomas and increases the tumorigenicity of cells injected in nude mice. Activation of DOL54 requires an intact DNA-binding and dimerization domain in TLS-CHOP, a suitable cellular dimerization partner, and depends on the TLS N terminus. Normal adipocytic differentiation is associated with an early and transient expression of DOL54, and the gene encodes a secreted protein that is tightly associated with the cell surface or extracellular matrix. TLS-CHOP thus leads to the unscheduled expression of a gene that is normally associated with adipocytic differentiation.  (+info)

Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. (2/224)

We have previously developed an assay to measure DNA homologous pairing activities in crude extracts: The POM blot. In mammalian nuclear extracts, we detected two major DNA homologous pairing activities: POMp100 and POMp75. Here, we present the purification and identification of POMp75 as the pro-oncoprotein TLS/FUS. Because of the pro-oncogene status of TLS/FUS, we studied in addition, the relationships between cell proliferation and POM activities. We show that transformation of human fibroblasts by SV40 large T antigen results in a strong increase of both POMpl00 and TLS/POMp75 activities. Although detectable levels of both POMp100 and TLS/POMp75 are observed in non-immortalized fibroblasts or lymphocytes, fibroblasts at mid confluence or lymphocytes stimulated by phytohaemaglutinin, show higher levels of POM activities. Moreover, induction of differentiation of mouse F9 line by retinoic acid leads to the inhibition of both POMp100 and TLS/POMp75 activities. Comparison of POM activity of TLS/FUS with the amount of TLS protein detected by Western blot, suggests that the POM activity could be regulated by post-translation modification. Taken together, these results indicate that POMp100 and TLS/POMp75 activities are present in normal cells but are connected to cell proliferation. Possible relationship between cell proliferation, response to DNA damage and DNA homologous pairing activity of the pro-oncoprotein TLS/FUS are discussed.  (+info)

Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). (3/224)

The FUS (TLS)-ERG chimeric protein associated with t(16;21)(p11;q22) acute myeloid leukemia is structurally similar to the Ewing's sarcoma chimeric transcription factor EWS-ERG. We found that both FUS-ERG and EWS-ERG could induce anchorage-independent proliferation of the mouse fibroblast cell line NIH 3T3. However, only FUS-ERG was able to inhibit the differentiation into neutrophils of a mouse myeloid precursor cell line L-G and induce its granulocyte colony-stimulating factor-dependent growth. We constructed several deletion mutants of FUS-ERG lacking a part of the N-terminal FUS region. A deletion mutant lacking the region between amino acids 1 and 173 (exons 1 to 5) lost the NIH 3T3-transforming activity but retained the L-G-transforming activity. On the other hand, a mutant lacking the region between amino acids 174 and 265 (exons 6 and 7) lost the L-G-transforming activity but retained the NIH 3T3-transforming activity. These results indicate that the N-terminal region of FUS contains two independent functional domains required for the NIH 3T3 and L-G transformation, which we named TR1 and TR2, respectively. Although EWS intrinsically possessed the TR2 domain, the EWS-ERG construct employed lacked the EWS sequence containing this domain. Since the TR2 domain is always found in chimeric proteins identified from t(16;21) leukemia patients but not in chimeric proteins from Ewing's sarcoma patients, it seems that the TR2 function is required only for the leukemogenic potential. In addition, we identified three cellular genes whose expression was altered by ectopic expression of FUS-ERG and found that these are regulated in either a TR1-dependent or a TR2-dependent manner. These results suggest that FUS-ERG may activate two independent oncogenic pathways during the leukemogenic process by modulating the expression of two different groups of genes simultaneously.  (+info)

Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. (4/224)

Extraskeletal myxoid chondrosarcomas (EMCs) are characterized by a recurrent t(9;22)(q22;q12) translocation, resulting in the fusion of the EWS gene in 22q12 and the TEC gene in 9q22. Here we report that a third member of the EWS, TLS/FUS gene family, TAF2N, can replace EWS as a fusion partner to TEC in EMC. Two tumors, one with a novel t(9;17)(q22;q11) variant translocation and one with an apparently normal karyotype, expressed TAF2N-TEC fusion transcripts. In both cases, the chimeric transcripts were shown to contain exon 6 of TAF2N fused to the entire coding region of TEC. This transcript is structurally and functionally very similar to the EWS-TEC fusions. The exchange of the EWS NH2-terminal part with the TAF2N NH2-terminal part in EMC further underscores the oncogenic potential of these protein domains as partners in fusion genes.  (+info)

Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. (5/224)

Homologous recombination plays a fundamental role in DNA double-strand break repair. Previously, we detected two mammalian nuclear proteins of 100 and 75 kDa (POMp100 and POMp75, respectively) that are able to promote homologous DNA pairing, a key step in homologous recombination. Here we describe the identification of human (h) POMp75 as the pro-oncoprotein TLS/FUS. hPOMp75/TLS binds both single- and double-stranded DNAs and mediates annealing of complementary DNA strands. More important, it promotes the uptake of a single-stranded oligonucleotide into a homologous superhelical DNA to form a D-loop. The formation of a D-loop is an essential step in DNA double-strand break repair through recombination. DNA annealing and D-loop formation catalyzed by hPOMp75/TLS require Mg(2+) and are ATP-independent. Interestingly, the oncogenic fusion form TLS-CHOP is not able to promote DNA pairing. These data suggest a possible role for hPOMp75/TLS in maintenance of genomic integrity.  (+info)

Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. (6/224)

TLS (also known as FUS) is an RNA-binding protein that contributes the N-terminal half of fusion oncoproteins implicated in the development of human liposarcomas and leukemias. Here we report that male mice homozygous for an induced mutation in TLS are sterile with a marked increase in the number of unpaired and mispaired chromosomal axes in pre-meiotic spermatocytes. Nuclear extracts from TLS(-/-) testes lack an activity capable of promoting pairing between homologous DNA sequences in vitro, and TLS(-/-) mice and embryonic fibroblasts exhibit increased sensitivity to ionizing irradiation. These results are consistent with a role for TLS in homologous DNA pairing and recombination.  (+info)

TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. (7/224)

The translocation liposarcoma (TLS) gene is fused to the ETS-related gene (ERG) in human myeloid leukemia, resulting in the generation of a TLS-ERG protein. We demonstrate that both TLS and the TLS-ERG leukemia fusion protein bind to RNA polymerase II through the TLS N-terminal domain, which is retained in the fusion protein; however, TLS recruits members of the serine-arginine (SR) family of splicing factors through its C-terminal domain, whereas the TLS-ERG fusion protein lacks the ability to recruit SR proteins due to replacement of the C-terminal domain by the fusion partner ERG. In transient-transfection assays, the TLS-ERG fusion protein inhibits E1A pre-mRNA splicing mediated by these TLS-associated SR proteins (TASR), and stable expression of the TLS-ERG fusion protein in K562 cells alters the splicing profile of CD44 mRNA. These results suggest that TLS fusion proteins may lead to cellular abnormalities by interfering with the splicing of important cellular regulators.  (+info)

The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. (8/224)

The characteristic t(12;16)(q13;p11) chromosomal translocation, which leads to gene fusion that encodes the FUS-CHOP chimeric protein, is associated with human liposarcomas. The altered expression of FUS-CHOP has been implicated in a characteristic subgroup of human liposarcomas. We have introduced the FUS-CHOP transgene into the mouse genome in which the expression of the transgene is successfully driven by the elongation factor 1alpha (EF1alpha) promoter to all tissues. The consequent overexpression of FUS-CHOP results in most of the symptoms of human liposarcomas, including the presence of lipoblasts with round nuclei, accumulation of intracellular lipid, induction of adipocyte-specific genes and a concordant block in the differentiation program. We have demonstrated that liposarcomas in the FUS-CHOP transgenic mice express high levels of the adipocyte regulatory protein PPARgamma, whereas it is not expressed in embryonic fibroblasts from these animals following induction to differentiation toward the adipocyte lineage, indicating that the in vitro system does not really reflect the in vivo situation and the developmental defect is downstream of PPARgamma expression. No tumors of other tissues were found in these transgenic mice despite widespread activity of the EF1alpha promoter. This establishes FUS-CHOP overexpression as a key determinant of human liposarcomas and provide the first in vivo evidence for a link between a fusion gene created by a chromosomal translocation and a solid tumor.  (+info)

FUS (Fused in Sarcoma) is a protein that in humans is encoded by the FUS gene. It is primarily located in the nucleus of the cell, but can also be found in the cytoplasm. FUS belongs to the family of RNA-binding proteins, which means it has the ability to bind to RNA molecules and play a role in post-transcriptional regulation of gene expression.

FUS has several functions, including:

1. Transcriptional regulation: FUS can interact with transcription factors and modulate the transcription of genes.
2. mRNA processing: FUS is involved in various aspects of mRNA processing, such as splicing, transport, localization, and stability.
3. DNA repair: FUS plays a role in DNA damage response and repair mechanisms.
4. Translational regulation: FUS can also regulate translation by interacting with ribosomes and other translational factors.

Mutations in the FUS gene have been associated with several neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). These mutations often lead to an abnormal cytoplasmic accumulation of FUS protein, which can form aggregates and contribute to the pathogenesis of these diseases.

RNA-binding proteins (RBPs) are a class of proteins that selectively interact with RNA molecules to form ribonucleoprotein complexes. These proteins play crucial roles in the post-transcriptional regulation of gene expression, including pre-mRNA processing, mRNA stability, transport, localization, and translation. RBPs recognize specific RNA sequences or structures through their modular RNA-binding domains, which can be highly degenerate and allow for the recognition of a wide range of RNA targets. The interaction between RBPs and RNA is often dynamic and can be regulated by various post-translational modifications of the proteins or by environmental stimuli, allowing for fine-tuning of gene expression in response to changing cellular needs. Dysregulation of RBP function has been implicated in various human diseases, including neurological disorders and cancer.

RNA (Ribonucleic Acid) is a single-stranded, linear polymer of ribonucleotides. It is a nucleic acid present in the cells of all living organisms and some viruses. RNAs play crucial roles in various biological processes such as protein synthesis, gene regulation, and cellular signaling. There are several types of RNA including messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). These RNAs differ in their structure, function, and location within the cell.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Ribonucleoproteins (RNPs) are complexes composed of ribonucleic acid (RNA) and proteins. They play crucial roles in various cellular processes, including gene expression, RNA processing, transport, stability, and degradation. Different types of RNPs exist, such as ribosomes, spliceosomes, and signal recognition particles, each having specific functions in the cell.

Ribosomes are large RNP complexes responsible for protein synthesis, where messenger RNA (mRNA) is translated into proteins. They consist of two subunits: a smaller subunit containing ribosomal RNA (rRNA) and proteins that recognize the start codon on mRNA, and a larger subunit with rRNA and proteins that facilitate peptide bond formation during translation.

Spliceosomes are dynamic RNP complexes involved in pre-messenger RNA (pre-mRNA) splicing, where introns (non-coding sequences) are removed, and exons (coding sequences) are joined together to form mature mRNA. Spliceosomes consist of five small nuclear ribonucleoproteins (snRNPs), each containing a specific small nuclear RNA (snRNA) and several proteins, as well as numerous additional proteins.

Other RNP complexes include signal recognition particles (SRPs), which are responsible for targeting secretory and membrane proteins to the endoplasmic reticulum during translation, and telomerase, an enzyme that maintains the length of telomeres (the protective ends of chromosomes) by adding repetitive DNA sequences using its built-in RNA component.

In summary, ribonucleoproteins are essential complexes in the cell that participate in various aspects of RNA metabolism and protein synthesis.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Heterogeneous Nuclear Ribonucleoproteins (hnRNPs) are a type of nuclear protein complex associated with nascent RNA transcripts in the nucleus of eukaryotic cells. They play crucial roles in various aspects of RNA metabolism, including processing, transport, stability, and translation.

The term "heterogeneous" refers to the diverse range of proteins that make up these complexes, while "nuclear" indicates their location within the nucleus. The hnRNPs are composed of a core protein component and associated RNA molecules, primarily heterogeneous nuclear RNAs (hnRNAs) or pre-messenger RNAs (pre-mRNAs).

There are over 20 different hnRNP proteins identified so far, each with distinct functions and structures. Some of the well-known hnRNPs include hnRNP A1, hnRNP C, and hnRNP U. These proteins contain several domains that facilitate RNA binding, protein-protein interactions, and post-translational modifications.

The primary function of hnRNPs is to regulate gene expression at the post-transcriptional level by interacting with RNA molecules. They participate in splicing, 3' end processing, export, localization, stability, and translation of mRNAs. Dysregulation of hnRNP function has been implicated in various human diseases, including neurological disorders and cancer.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

Hu paraneoplastic encephalomyelitis antigens are a group of neuronal intracellular antigens associated with paraneoplastic neurological disorders (PNDs). PNDs are a group of rare, degenerative conditions that affect the nervous system and can occur in patients with cancer. The Hu antigens are part of a family of proteins known as onconeural antigens, which are expressed in both cancer cells and normal neurons.

The Hu antigens include three main proteins: HuD, HuC, and Rb/p75. These proteins are involved in the regulation of gene expression and are found in the nucleus and cytoplasm of neuronal cells. In patients with PNDs associated with Hu antigens, the immune system mistakenly recognizes these antigens as foreign and mounts an immune response against them. This leads to inflammation and damage to the nervous system, resulting in various neurological symptoms such as muscle weakness, sensory loss, and autonomic dysfunction.

Paraneoplastic encephalomyelitis is a specific type of PND that affects both the brain (encephalitis) and spinal cord (myelitis). It is often associated with small cell lung cancer but can also occur in other types of cancer. The presence of Hu antibodies in the blood or cerebrospinal fluid is a useful diagnostic marker for this condition, although not all patients with Hu-associated PNDs will have detectable Hu antibodies.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

RNA splicing is a post-transcriptional modification process in which the non-coding sequences (introns) are removed and the coding sequences (exons) are joined together in a messenger RNA (mRNA) molecule. This results in a continuous mRNA sequence that can be translated into a single protein. Alternative splicing, where different combinations of exons are included or excluded, allows for the creation of multiple proteins from a single gene.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

RNA stability refers to the duration that a ribonucleic acid (RNA) molecule remains intact and functional within a cell before it is degraded or broken down into its component nucleotides. Various factors can influence RNA stability, including:

1. Primary sequence: Certain sequences in the RNA molecule may be more susceptible to degradation by ribonucleases (RNases), enzymes that break down RNA.
2. Secondary structure: The formation of stable secondary structures, such as hairpins or stem-loop structures, can protect RNA from degradation.
3. Presence of RNA-binding proteins: Proteins that bind to RNA can either stabilize or destabilize the RNA molecule, depending on the type and location of the protein-RNA interaction.
4. Chemical modifications: Modifications to the RNA nucleotides, such as methylation, can increase RNA stability by preventing degradation.
5. Subcellular localization: The subcellular location of an RNA molecule can affect its stability, with some locations providing more protection from ribonucleases than others.
6. Cellular conditions: Changes in cellular conditions, such as pH or temperature, can also impact RNA stability.

Understanding RNA stability is important for understanding gene regulation and the function of non-coding RNAs, as well as for developing RNA-based therapeutic strategies.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

Small interfering RNA (siRNA) is a type of short, double-stranded RNA molecule that plays a role in the RNA interference (RNAi) pathway. The RNAi pathway is a natural cellular process that regulates gene expression by targeting and destroying specific messenger RNA (mRNA) molecules, thereby preventing the translation of those mRNAs into proteins.

SiRNAs are typically 20-25 base pairs in length and are generated from longer double-stranded RNA precursors called hairpin RNAs or dsRNAs by an enzyme called Dicer. Once generated, siRNAs associate with a protein complex called the RNA-induced silencing complex (RISC), which uses one strand of the siRNA (the guide strand) to recognize and bind to complementary sequences in the target mRNA. The RISC then cleaves the target mRNA, leading to its degradation and the inhibition of protein synthesis.

SiRNAs have emerged as a powerful tool for studying gene function and have shown promise as therapeutic agents for a variety of diseases, including viral infections, cancer, and genetic disorders. However, their use as therapeutics is still in the early stages of development, and there are challenges associated with delivering siRNAs to specific cells and tissues in the body.

I'm happy to help! However, it seems there might be a slight misunderstanding in your question. RNA, or ribonucleic acid, is typically single-stranded. Unlike DNA, which is double-stranded and forms a double helix, RNA usually exists as a single strand of nucleotides.

There are exceptions to this rule, such as certain types of RNA molecules that can form double-stranded structures in specific contexts. For example:

1. Double-Stranded RNA (dsRNA) viruses: These viruses have genomes made entirely of RNA, which is double-stranded throughout or partially double-stranded. The dsRNA viruses include important pathogens such as rotaviruses and reoviruses.
2. Hairpin loops in RNA structures: Some single-stranded RNA molecules can fold back on themselves to form short double-stranded regions, called hairpin loops, within their overall structure. These are often found in ribosomal RNA (rRNA), transfer RNA (tRNA), and messenger RNA (mRNA) molecules.

So, while 'double-stranded RNA' is not a standard medical definition for RNA itself, there are specific instances where RNA can form double-stranded structures as described above.

RNA editing is a process that alters the sequence of a transcribed RNA molecule after it has been synthesized from DNA, but before it is translated into protein. This can result in changes to the amino acid sequence of the resulting protein or to the regulation of gene expression. The most common type of RNA editing in mammals is the hydrolytic deamination of adenosine (A) to inosine (I), catalyzed by a family of enzymes called adenosine deaminases acting on RNA (ADARs). Inosine is recognized as guanosine (G) by the translation machinery, leading to A-to-G changes in the RNA sequence. Other types of RNA editing include cytidine (C) to uridine (U) deamination and insertion/deletion of nucleotides. RNA editing is a crucial mechanism for generating diversity in gene expression and has been implicated in various biological processes, including development, differentiation, and disease.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Nuclear factor 90 proteins (NF-90) are a family of ubiquitously expressed nuclear factors that play important roles in regulating gene expression. They were originally discovered as proteins that bind to the IL-6 response element in the promoter region of the acute phase genes. NF-90 proteins have since been shown to be involved in various cellular processes, including transcriptional regulation, RNA processing, and translation.

NF-90 proteins are composed of two subunits, NF-90A and NF-90B, which form a heterodimer that binds to DNA and RNA. They have multiple functional domains, including an N-terminal double-stranded RNA binding domain (dsRBD), a central dimerization domain, and a C-terminal glycine-rich region involved in protein-protein interactions.

NF-90 proteins are known to interact with various transcription factors, chromatin modifiers, and RNA-binding proteins, suggesting that they function as adaptors or scaffolds in the assembly of large protein complexes involved in gene regulation. They have been shown to regulate the expression of genes involved in inflammation, immune response, cell cycle, apoptosis, and stress response.

In addition to their role in transcriptional regulation, NF-90 proteins also play important roles in RNA metabolism. They bind to double-stranded RNA (dsRNA) and regulate the stability and translation of mRNAs encoding cytokines, growth factors, and other regulatory molecules. NF-90 proteins have been shown to interact with microRNAs (miRNAs), small non-coding RNAs that regulate gene expression by binding to target mRNAs, and modulate their activity.

Overall, NF-90 proteins are important regulators of gene expression at multiple levels, including transcriptional regulation, RNA processing, and translation. Dysregulation of NF-90 function has been implicated in various human diseases, including cancer, inflammation, and neurodegenerative disorders.

Post-transcriptional RNA processing refers to the modifications and regulations that occur on RNA molecules after the transcription of DNA into RNA. This process includes several steps:

1. 5' capping: The addition of a cap structure, usually a methylated guanosine triphosphate (GTP), to the 5' end of the RNA molecule. This helps protect the RNA from degradation and plays a role in its transport, stability, and translation.
2. 3' polyadenylation: The addition of a string of adenosine residues (poly(A) tail) to the 3' end of the RNA molecule. This process is important for mRNA stability, export from the nucleus, and translation initiation.
3. Intron removal and exon ligation: Eukaryotic pre-messenger RNAs (pre-mRNAs) contain intronic sequences that do not code for proteins. These introns are removed by a process called splicing, where the flanking exons are joined together to form a continuous mRNA sequence. Alternative splicing can lead to different mature mRNAs from a single pre-mRNA, increasing transcriptomic and proteomic diversity.
4. RNA editing: Specific nucleotide changes in RNA molecules that alter the coding potential or regulatory functions of RNA. This process is catalyzed by enzymes like ADAR (Adenosine Deaminases Acting on RNA) and APOBEC (Apolipoprotein B mRNA Editing Catalytic Polypeptide-like).
5. Chemical modifications: Various chemical modifications can occur on RNA nucleotides, such as methylation, pseudouridination, and isomerization. These modifications can influence RNA stability, localization, and interaction with proteins or other RNAs.
6. Transport and localization: Mature mRNAs are transported from the nucleus to the cytoplasm for translation. In some cases, specific mRNAs are localized to particular cellular compartments to ensure local protein synthesis.
7. Degradation: RNA molecules have finite lifetimes and undergo degradation by various ribonucleases (RNases). The rate of degradation can be influenced by factors such as RNA structure, modifications, or interactions with proteins.

"FUS - RNA-binding protein FUS - Homo sapiens (Human) - FUS gene & protein". www.uniprot.org. Retrieved 2019-03-13. Kino Y, ... FUS/TLS is a member of the FET protein family that also includes the EWS protein, the TATA-binding protein TBP-associated ... a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA ... Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994). "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid ...
... protein, is associated with 1-5% of familial ALS and less than 1% of sporadic ALS. FUS is an RNA-binding protein with a similar ... One proposed mechanism of ALS incorporating both the genetic mutations of RNA binding proteins and oxidative stress, suggests ... was the first proof that RNA processing defects lead to protein inclusions typical in RNA, and contribute to the pathogenesis ... The TDP-43 protein, coded for by the TARDBP gene, is responsible for regulation of RNA expression. The discovery of mutations ...
She has investigated how the RNA-binding protein mutant FUS behaves in mouse models. Fisher serves as a Council Member at the ... Fisher develops new models for Amyotrophic lateral sclerosis (ALS) that occurs due to mutations in the gene FUS. ALS is a form ... In cells, dynein is the motor protein that moves cargos toward the minus end of microtubules. These mutants were named Loa ( ... The sex-determining region of the human Y chromosome encodes a finger protein Genealogies of mouse inbred strains Mutations in ...
Mutations in the FUS gene, that encodes an RNA/DNA binding protein, are causally linked to ALS. ALS patients with such ... In response to DNA damage, the FUS protein also interacts with histone deacetylase I, a protein employed in epigenetic ... The protein encoded by the FUS gene is employed in the DNA damage response. It is recruited to DNA double-strand breaks and ... One such protein pathway is the REST co-repressor complex pathway. There are also several non-coding RNAs that regulate neural ...
... and FUS proteins are members of the FET protein family of RNA binding proteins. They are partners in various fusion proteins ... These genes include TAF2N (17q11), also termed TAF15, encoding an RNA-binding protein which is a component of transcription ... "TAF15 TATA-box binding protein associated factor 15 [Homo sapiens (Human)] - Gene - NCBI". Rubin, Brian P.; Lazar, Alexander J. ... "The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein". Molecular Brain Research. ...
The 5' UTR is bound by the RNA binding proteins RBMX1, FUS, SFRS1, ACO1, and NONO. The 3' UTR is bound by EIF4B, A2BP1, and ... "The Database of RNA-binding protein specificities". RBPDB. University of Toronto. Retrieved 1 May 2018. Stothard, Paul. " ... Protein FAM208B (family with sequence similarity 208 member b) is a protein that in humans is encoded by the FAM208B gene. The ... The promoter contains binding sites for Ikaros2, Nuclear Factor Y, and at least three binding sites for Pleomorphic adenoma ...
Ito D, Suzuki N (October 2011). "Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS ... Wolozin B, Apicco D (2015). "RNA Binding Proteins and the Genesis of Neurodegenerative Diseases". GeNeDis 2014. Advances in ... and TAR DNA-binding protein-43 (TDP-43). In all of these instances, an aberrant form of the protein itself appears to be the ... proteins that assist protein folding) may antagonize proteotoxicity during aging and in protein misfolding-diseases to maintain ...
... and FUS-ERG in acute myeloid leukemia. DNA binding protein ERG fuses with RNA binding proteins EWS and TLS/FUS in Ewing's ... Ichikawa H, Shimizu K, Hayashi Y, Ohki M (Jun 1994). "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid ... Ichikawa H, Shimizu K, Hayashi Y, Ohki M (Jun 1994). "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid ... translocation in myeloid leukemia fuses TLS/FUS to ERG which disrupts the natural TLS/FUS RNA binding domain, and instead ...
... a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA ... "Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins". ... "Entrez Gene: TAF15 TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa". Bertolotti A, Melot T, ... TATA-binding protein-associated factor 2N is a protein that in humans is encoded by the TAF15 gene. Initiation of transcription ...
"EWSR1 EWS RNA binding protein 1 [Homo sapiens (Human)] - Gene - NCBI". "FUS FUS RNA binding protein [Homo sapiens (Human)] - ... the FUS (i.e. fused in sarcoma) protein encoded by the FUS gene (also termed the FUS RNA binding protein, TLS, asTLS, ALS6, ... the EWSR1 protein encoded by the EWSR1 gene (also termed the Ewing sarcoma RNA binding protein, EWS RNA binding protein 1, or ... FET proteins are abundantly expressed in virtually all tissues examined. They are RNA-binding proteins. By binding to their RNA ...
1505 Immunochemistry may identify RNA-binding protein FUS, phosphorylated tau protein or ubiquitin if frontotemporal lobar ... with frontotemporal lobar degeneration not caused by tau proteinopathy occurred because of a RNA-binding protein FUS (FUS) ... determined that amyotrophic lateral sclerosis and frontotemporal lobar degeneration are often TAR DNA-binding protein 43 (TDP- ... Hippocampal sclerosis occurs in about 66% of those with frontotemporal lobar degeneration arising from TDP-43 or FUS ...
... or FUS may refer to: FUS (gene) ("Fused In Sarcoma"), a gene encoding an RNA-binding protein found in human cancers and ... Look up fus in Wiktionary, the free dictionary. ... page lists articles associated with the title Fus. If an ...
FUS RNA Binding Protein (FUS), mitogen-activated protein kinase 9 (MAPK9), STN1 subunit of CST complex (OBFC1), protein ... cAMP-responsive element binding proteins, PAR/bZIP family and vertebrate TATA binding protein factor. SMCO3 is 225 amino acid ... SMCO3 is flanked by WW domain binding protein 11 (WBP11) and Ecto-ADP-ribosyltransferase 4 (ART4) on the minus strand and ... "Statistical Analysis of Protein Sequences (EMBL-EBI)". www.ebi.ac.uk. Retrieved 2019-05-05. "SMCO3 single-pass membrane protein ...
RBPmap, which maps predicted binding sites of RNA binding proteins, showed multiple conserved motifs in evolution relative to ... the human ISLR mRNA transcript variant 1 sequence such as: BRUNOL6 CPEB2 and CPEB4 ESRP2 FMR1 FUS FXR1 and FXR2 G3BP2 HNRNPA1, ... "RBPmap - Motifs Analysis and Prediction of RNA Binding Proteins". rbpmap.technion.ac.il. Archived from the original on 22 ... Based on Protein Abundance Database (PAXdb 4.1), the human protein of ISLR is shown with high protein abundance (ppm value > 1 ...
... which also contains the double-stranded RNA binding protein DGCR8 (called Pasha in D. melanogaster and C. elegans). DGCR8 is ... The Drosha complex also contains several auxiliary factors such as EWSR1, FUS, hnRNPs, p68, and p72. Both Drosha and DGCR8 are ... Sloan, K. E., Gleizes, P. E., & Bohnsack, M. T. (2016). Nucleocytoplasmic transport of RNAs and RNA-protein complexes. Journal ... Wu H, Xu H, Miraglia LJ, Crooke ST (November 2000). "Human RNase III is a 160-kDa protein involved in preribosomal RNA ...
"Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins". ... The normal EWS gene encodes an RNA binding protein closely related to FUS (gene) and TAF15, all of which have been associated ... RNA-binding protein EWS is a protein that in humans is encoded by the EWSR1 gene on human chromosome 22, specifically 22q12.2. ... "Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS". Curr. Biol. ...
Crozat A, Aman P, Mandahl N, Ron D (June 1993). "Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma". ... Mutations or fusions of CHOP (e.g. with FUS to form FUS-CHOP) can cause Myxoid liposarcoma. GRCh38: Ensembl release 89: ... It is a member of the CCAAT/enhancer-binding protein (C/EBP) family of DNA-binding transcription factors. The protein functions ... Qiao D, Im E, Qi W, Martinez JD (June 2002). "Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 ...
Crozat A, Aman P, Mandahl N, Ron D (1993). "Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma". Nature ... The FUS-DDIT3 fusion gene forms by a merger of part of the FUS FET gene family gene normally located at band 11.2 on the short ... This fusion gene is notated as t(12;16)(q13;p11). Preclinical studies, i.e. laboratory studies, suggest that the FUS-DDIT3 ... The neoplastic cells in these neoplasms contain chromosomal translocations which create one of two fusion genes: the FUS-DDIT3 ...
A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR". Biochemistry. ... ILF3 has been shown to interact with: DNA-PKcs, FUS, PRMT1 Protein kinase R, and XPO5. C5orf36 Small NF90/ILF3-associated RNAs ... A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR". Biochemistry. ... a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR". The Journal of ...
The hnRNPs are RNA-binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with ... HNRNPR has been shown to interact with SMN1, PRMT1, TDP-43, and FUS/TLS. ENSG00000125944 GRCh38: Ensembl release 89: ... The protein encoded by this gene has three repeats of RRM domains that bind to RNAs and also contains a nuclear localization ... The hnRNP proteins have distinct nucleic acid binding properties. ...
UTR contains the poly-a signal as well as multiple ELAVL1 miRNA binding sites. ELAVL1 is a necessary RNA binding protein during ... It binds to the mRNA in the presence of ATP. FUS actually mediates gene silencing. It has also been clinically linked with ALS ... Myeloid zinc finger MZF1 Zinc finger protein 750 FOXP1 KRAB-containing zinc finger protein 300 The KIAA2013 protein has been ... "LOC728138 protein [Homo sapiens] - Protein - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2021-12-18. "ortholog_gene_90231[group] - ...
RNA-binding protein FUS MeSH D12.776.624.664.700.957 - stathmin MeSH D12.776.624.664.700.967 - wnt1 protein MeSH D12.776. ... RNA-binding protein FUS MeSH D12.776.664.962.500.500.100 - heterogeneous-nuclear ribonucleoprotein group a-b MeSH D12.776. ... proto-oncogene proteins c-raf MeSH D12.776.624.664.700.205 - RNA-binding protein EWS MeSH D12.776.624.664.700.250 - lymphocyte ... binding protein i MeSH D12.776.664.962.452.500 - poly(a)-binding protein ii MeSH D12.776.664.962.500.500 - heterogeneous- ...
FUS-interacting serine-arginine-rich protein 1 is a protein that in humans is encoded by the SFRS13A gene. This gene product is ... Members of this family are characterized by N-terminal RNP1 and RNP2 motifs, which are required for binding to RNA, and ... "TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins". Mol. Cell. Biol. 20 (10): 3345-54 ... "TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins". Mol. Cell. Biol. 20 (10): 3345-54 ...
... zinc could bind to RNA binding domain of TDP-43 and induce the formation of amyloid-like aggregates in vitro. TDP-43 protein is ... Ratti A, Buratti E (August 2016). "Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins". Journal of ... TAR DNA-binding protein 43 (TDP-43, transactive response DNA binding protein 43 kDa) is a protein that in humans is encoded by ... Much like 70 other RNA binding proteins, TDP-43 bears a Q/N rich domain [344, 366] which resembles yeast prion sequence. This ...
The FUS protein was another one found with a binding site on a predicted stem loop. The gene encodes for a protein which ... Unconserved amino acids, miRNA, stem-loop formations, and RNA binding proteins (RBPs) are shown on the diagram (Figure 2-3). ... Zinc finger protein 226 is a protein that in humans is encoded by the ZNF226 gene. The zinc finger protein 226 is also known as ... Arginine methylation of cellular nucleic acid binding protein (CNBP), a zinc finger protein, has shown to impede its ability to ...
Stem-loop I binds to the U1-70K protein, stem-loop II binds to the U1 A protein, stem-loops III and IV bind to the core RNP ... the Sm proteins and U1 snRNA) were found to co-mislocalize to the cytoplasm with the mutant version of a protein called FUS ( ... U1 spliceosomal RNA is the small nuclear RNA (snRNA) component of U1 snRNP (small nuclear ribonucleoprotein), an RNA-protein ... "Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin ...
... and RNA-binding protein. PURA is expressed in every human tissue, where it exists as a protein of 322 amino acids. According to ... Pur-alpha also reverses neuronal changes caused by defects in the gene, FUS, which can lead to ALS. The mechanism of action of ... Pur-alpha then binds to the Tat protein itself. Pur-alpha also binds Cyclin T1, a regulatory partner of Cdk9 protein kinase, ... a single-stranded DNA and RNA binding protein, which is involved in the transcription of the BC1 RNA gene". Biochemical and ...
RNA-binding protein ews MeSH D12.776.157.725.500.500.905 - RNA-binding protein fus MeSH D12.776.157.725.500.625 - ribonuclease ... ral gtp-binding proteins MeSH D12.776.157.325.515.462 - ran gtp-binding protein MeSH D12.776.157.325.515.475 - rap gtp-binding ... gtp-binding protein alpha subunits, g12-g13 MeSH D12.776.157.325.332.100.200 - gtp-binding protein alpha subunits, gi-go MeSH ... gtp-binding protein alpha subunit, gi2 MeSH D12.776.157.325.332.100.300 - gtp-binding protein alpha subunits, gq-g11 MeSH ...
It was found in many eukaryotic proteins. The largest group of single strand RNA-binding protein is the eukaryotic RNA ... FUS; FUSIP1; G3BP; G3BP1; G3BP2; GRSF1; HNRNPL; HNRPA0; HNRPA1; HNRPA2B1; HNRPA3; HNRPAB; HNRPC; HNRPCL1; HNRPD; HNRPDL; HNRPF ... RNA recognition motif, RNP-1 is a putative RNA-binding domain of about 90 amino acids that are known to bind single-stranded ... binding protein is necessary and sufficient for RNA binding and cell viability". Mol. Cell. Biol. 7 (9): 3268-76. doi:10.1128/ ...
The type of cargo proteins that Transportin 1 can carry into the nucleus include RNA-binding proteins (such as hnRNP A1 and ... FUS) mutations disrupt Transportin-mediated nuclear import". EMBO J. 29 (16): 2841-57. doi:10.1038/emboj.2010.143. PMC 2924641 ... However, Transportin-1 can directly bind to the cargo proteins and may not need importin alpha subunit to do it. Transportin-1 ... Bonifaci N, Moroianu J, Radu A, Blobel G (Jun 1997). "Karyopherin beta2 mediates nuclear import of a mRNA binding protein". ...
"FUS - RNA-binding protein FUS - Homo sapiens (Human) - FUS gene & protein". www.uniprot.org. Retrieved 2019-03-13. Kino Y, ... FUS/TLS is a member of the FET protein family that also includes the EWS protein, the TATA-binding protein TBP-associated ... a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA ... Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994). "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid ...
We identified a cohort of proteins involved in translation, splicing, and RNA export to be associated with the FUS inclusions. ... FUS performs a diverse set of cellular functions, including being a major regulator of RNA metabolism. FUS undergoes liquid- ... Their interaction with FUS varied greatly in their requirements for RNA. Most notably, FUS interacted with hnRNPA1 and Matrin-3 ... proteins also known to cause familial ALS. Immunofluorescent staining of proteins interacting with mutant FUS were localized to ...
Nucleoproteins - RNA-Binding Protein FUS PubMed MeSh Term *Overview. Overview. subject area of * Biochemical Properties and ... Nucleic acid-binding specificity of human FUS protein Journal Article * Quantitative proteomics identifies proteins that resist ... RNA Seeds Higher-Order Assembly of FUS Protein Journal Article broader concept * Nucleoproteins - Heterogeneous-Nuclear ... FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2 Journal Article ...
Many proteins found in pathological inclusions are known to undergo liquid-liquid phase separation, a reversible process of ... Protein aggregation is the main hallmark of neurodegenerative diseases. ... Keywords: FUS; RNA-binding proteins; TDP-43; Tau; biomolecular condensates; liquid-liquid phase separation; neurodegeneration; ... Here, we review similarities and differences among four main proteins, α-synuclein, FUS, tau, and TDP-43, which are found ...
... for making a protein that is found within the cell nucleus in most tissues and is involved in many of the steps of protein ... URL of this page: https://medlineplus.gov/genetics/gene/fus/ FUS gene. FUS RNA binding protein ... change single protein building blocks in the FUS protein and often affect the region of the protein involved in DNA binding and ... The FUS protein attaches (binds) to DNA and regulates an activity called transcription, which is the first step in the ...
"Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS". Neurology. 77 (17): 1636-43. ... FTLD-FUS[55] Fused in sarcoma (FUS) protein Amyotrophic lateral sclerosis (ALS)[56][57] Superoxide dismutase, TDP-43, FUS, ... Wolozin B, Apicco D (2015). "RNA Binding Proteins and the Genesis of Neurodegenerative Diseases". GeNeDis 2014. Advances in ... and TAR DNA-binding protein-43 (TDP-43).[45] In all of these instances, an aberrant form of the protein itself appears to be ...
Function and Regulation of ALS/FTD-associated RNA Binding Protein FUS Tsai, Yueh-Lin 2021 Theses BiologyCytologyMolecular ... Studies on RNA Regulation: From Enhancer RNAs to RBBP6 Isoform3 Chen, Yaqiong 2019 Theses Molecular biologyRNAGenetic ... ProteinsRNA splicingScission (Chemistry)Messenger RNAMolecular biologyBiologyBiochemistry 22. Structural Studies of NediV-IRES- ... Messenger RNARNA-protein interactionsEukaryotic cellsBiologyBiochemistryMolecular biology 54. Modulation of touch sensitivity ...
Home > Protein > hnRNP P2 human. mouse. rat. New Protein Search:. RNA-binding protein FUS ... Protein Mutation Frequency in Cancer. The lollipop plot above illustrates recurrent (observed in 3 or more out of 4440 TCGA ...
FUS codes for FUS, another RNA-binding protein with a similar function to TDP-43, which can cause ALS when mutated.[61] It is ... There are a number of ALS genes that encode for RNA-binding proteins. The first to be discovered was TDP-43 protein,[77] a ... causing their respective proteins to aggregate in the cytoplasm.[83] Once these mutant RNA-binding proteins are misfolded and ... This also leads to decreased levels of RNA-binding protein in the nucleus, which may mean that their target RNA transcripts do ...
In one data set, mutants of a protein involved in RNA biogenesis and processing, human TAR DNA binding protein 43 (TDP-43), ... mutants of a protein involved in RNA biogenesis and processing, human TAR DNAbinding protein 43 (TDP-43), were expressed in S. ... Thus, understanding the relationship between protein evolution and aggregation is an important goal. Here, we analysed two deep ... Thus, understanding the relationship between protein evolution and aggregation is an important goal. Here, we analysed two deep ...
73] TDP-43 and FUS/TLS are DNA/RNA-binding proteins with striking structural and functional similarities, implicating ... FUS = fused-in-sarcoma protein; GFAP = glial fibrillary acidic protein; pNFP = phosphorylated neurofilament protein; pTau = ... FUS = fused-in-sarcoma protein; GFAP = glial fibrillary acidic protein; pNFP = phosphorylated neurofilament protein; pTau = ... Mutations in the transactive response (TAR) DNA-binding protein gene (TARDBP) on chromosome 1 (1p36.22), which codes for TDP-43 ...
TAR DNA binding protein-43 kDa). TDP-43 regulates RNA metabolism, trafficking, and localization of thousands of target genes. ... The effect on dendritic morphology is dependent on the RNA-binding ability of TDP-43. Thus, this model system will be useful in ... and are linked neuropathologically by the RNA binding protein TDP-43 ( ... FUS (Fused in Sarcoma, also known as TLS) is an RNA-binding protein that is genetically linked to ALS and FTD and is ...
... working in collaborations with labs to exploit three system to explore the basic function of the RNA-binding protein FUS. First ... They are also pursuing the role of FUS and noncoding RNAs in DNA damage repair. They believe that the function of FUS in ... Recent interests are RNA structure, nucleic acid-protein interactions interactions, and translational recoding via -1 ... to investigate the role of FUS as a scaffold protein to promote the formation of the Super Elongation Complex (SEC) both genome ...
... spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding ... The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic ... My belief is that viruses with altered DNA or RNA injected into a body may disturb the normal function of cells, and can cause ... The paper goes on to state that "The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS ...
Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains. ... 2014). ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 124(3):981-999. pdf file ... 2017). RNA-binding proteins with prion-like domains in health and disease. Biochem. J. 474(8):1417-1438. pdf file link cover (^ ... Gitler, A.D.^, and J. Shorter^. (2011). RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion. 5(3):179-187. ...
RNA: ENST00000568901.2 FUS-211, Transcript of FUS RNA binding protein, human. TSL 2. Gene FUS, Length 521 nt, Biotype retained ... Protein Status Prediction Score Prediction z-Score p-Value Fold Change FUS-211. ENST00000568901 NISCH. Q9Y2I1 1504 aa. 27.16. ... FUS-211. ENST00000568901 NACAD. O15069 1562 aa. 23.35. ■■□□□ 1.33. FUS-211. ENST00000568901 PABPN1. Q86U42 306 aa. Known RBP ... FUS-211. ENST00000568901 EIF4G1. Q04637 1599 aa. Known RBP. 22.47. ■■□□□ 1.19. FUS-211. ENST00000568901 SCRIB. Q14160 1630 aa. ...
Order FUS RNA capture probes. Buy raPOOLs now for your target gene also known as ALS6,ETM4,FUS1,HNRNPP2,POMP75,TLS,altFUS on ... This protein belongs to the FET family of RNA-binding proteins which have been implicated in cellular processes that include ... Buy raPOOLs for FUS. There is no existing raPOOL for your gene, hence a custom raPOOL set up service is required. Please add ... Includes design of new probes against target RNA. Charged on top of raPOOL 2, 5 or 10 price. Charged once only, subsequent ...
Thus TLS/FUS is both an "RNA and DNA G-quadruplex binding protein". In the C-terminal region of TLS/FUS, there is an Arg-Gly- ... 2014 DNA and RNA quadruplex-binding proteins. 2011 Structure of long human telomeric RNA (TERRA): G-quadruplexes formed by four ... Reference: 2014 DNA and RNA Quadruplex-Binding Proteins. Helicase proteins serve selectively to unwind G-quadraplexes, and when ... forms RNA G-quadruplexes and that the TERRA RNA G-quadruplex binds to telomere repeat binding factor 2 (TRF2). Here is an ...
RNA binding to EWS interferes with PKC phosphorylation. Several other RNA-binding proteins, including TLS/FUS and PSF, co- ... These data suggest that PKC may regulate interactions of EWS and other RNA-binding proteins with their RNA targets and that IQ ... PKC phosphorylation of these proteins also inhibits their binding to RNA in vitro. ... a nuclear RNA-binding prooncoprotein, contains an IQ domain, is phosphorylated by protein kinase C, and interacts with ...
Fused in sarcoma (FUS) is a DNA/RNA binding protein that is dysfunctional in various malignant tumors. However, the expression ... The Kaplan-Meier analysis was used to investigate the effect of these proteins on prognosis. The expressions of IL-13Rα2 were ... In the present study, the expression of IL-13Rα2 and FUS was measured in a glioma tissue array by immunohistochemistry. ... In HGG, IL-13Rα2 combined with nuclear and cytoplasmic co-localization of FUS was associated with worse OS. Multivariate ...
... a DNA/RNA binding protein). Five out of these ten knockdowns led to significant changes in circadian period or loss of ... Rnf152 and Ppp1r3c were not expressed in NIH 3T3 cells, so we substituted Nup62 (a nuclear pore complex factor) and Fus ( ... Phosphorylation and other protein-protein interaction studies provide evidence for how kinases regulate TF activity, ... ChIP studies provide binding evidence for a TF to a target gene promoter. Genetic studies provide directional evidence for how ...
It shows genes and PPIs with information about pathways, protein-protein interactions (PPIs), Gene Ontology (GO) annotations ... a web resource for human protein-protein interactions. ... RNA Polymerase II Distal Enhancer Sequence-specific DNA Binding ... Sequence-specific DNA Binding Transcription Factor Activity. *RNA Polymerase II Distal Enhancer Sequence-specific DNA Binding ... Protein-Protein Interactions. 185 interactors: AATF ACTL6A AES AGO1 AHR AKAP8 APBA2 AR ASCC1 ASCC2 ASCC3 BATF2 BRCA1 BRMS1 BTK ...
Protein Capture Reagents. *Protein tags. *Skeletal muscle. *Stem cell. *Transcription factors. *Xenopus ...
RNA-Binding Protein FUS Entry term(s). FUS Protein FUS RNA Binding Protein FUS RNA-Binding Protein Fusion Protein in Myxoid ... FUS RNA Binding Protein. FUS RNA-Binding Protein. Fusion Protein in Myxoid Liposarcoma. POMp75 Protein. RNA Binding Protein FUS ... POMp75 Protein RNA Binding Protein FUS RNA-Binding Protein, FUS TLS Protein Translocated in Liposarcoma Protein hnRNP P2 ... RNA-Binding Protein, FUS. TLS Protein. Translocated in Liposarcoma Protein. hnRNP P2. ...
Prion-like RNA binding proteins (RBPs) such as TDP43 and FUS are largely soluble in the nucleus but form solid pathological ... RNA buffers the phase separation behavior of prion-like RNA binding proteins.. Science, 360(6391) 918-921 (2018) Abstract. DOI ... Iron-regulatory protein-1 (IRP-1) plays a dual role as a regulatory RNA-binding protein and as a cytoplasmic aconitase. When ... Pentatricopeptide repeat (PPR) proteins form the largest known RNA-binding protein family, and are found in all eukaryotes, ...
RNA-Binding Proteins 53% * RNA-Binding Protein FUS 41% * Heterogeneous Nuclear Ribonucleoprotein A1 37% ... Currie, S. L. & Rosen, M. K., Jan 2022, In: RNA. 28, 1, p. 27-35 9 p.. Research output: Contribution to journal › Article › ... Bound nucleotide can control the dynamic architecture of monomeric actin. Ali, R., Zahm, J. A. & Rosen, M. K., Apr 2022, In: ... RNA sectors and allosteric function within the ribosome. Walker, A. S., Russ, W. P., Ranganathan, R. & Schepartz, A., Aug 2020 ...
Intrinsically Disordered Proteins 86% * Light 55% * RNA-Binding Protein FUS 35% * Protein 32% ... Optogenetic control of protein binding using light-switchable nanobodies. Gil, A. A., Carrasco-López, C., Zhu, L., Zhao, E. M. ... Development of light-responsive protein binding in the monobody non-immunoglobulin scaffold. Carrasco-López, C., Zhao, E. M., ... Protein Phase Separation Provides Long-Term Memory of Transient Spatial Stimuli. Dine, E., Gil, A. A., Uribe, G., Brangwynne, C ...
... protein complex, as well as other RNA-binding proteins. However, the researchers did not expect the second set of proteins ... Another interesting partner-FUS-appeared in the mass spec analysis. Researchers have long sought to connect TDP-43 and FUS in a ... RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine- ... Among proteins that bind polyglutamine, combined glutamine/asparagine regions are common. In TDP-43, the area that the ...
... calcium binding and coiled-coil domain 2; CIRBP: cold inducible RNA binding protein; COLGALT1: collagen beta(1-O) ... FUS: fused in sarcoma; HMGB1: high mobility group box 1; HMGB2: high mobility group box 2: HSP90AA1: heat shock protein 90: ... binding protein 1; TFEB: transcription factor EB; TOLLIP: toll interacting protein; UBE2G2: ubiquitin conjugating enzyme E2 G2 ... heat shock protein 8; HSPB1: heat shock protein 1; HSPH1: heat shock 105kDa/110kDa protein 1; LDAH: lipid droplet associated ...
Session 1- RNA Binding Proteins & RNAs in Neurodegeneration. 13:45 Professor Chris Shaw, ARPP21 is an ALS Gene: thinking ... 14:10 Priv-Doz, Dr Marc-David Ruepp, FUS-RNA interactions in health and disease ... 15:00 Dr Elsa Zacco, Natural RNA-protein interactions for preventing aberrant aggregation: the case of TDP-43 ... 15:10 Professor Peter Giese, Do deficits in synaptic protein synthesis underlie pathology and memory loss in Alzheimers ...
  • RNA-binding protein FUS/TLS (FUsed in Sarcoma/Translocated in LipoSarcoma), also known as heterogeneous nuclear ribonucleoprotein P2 is a protein that in humans is encoded by the FUS gene. (wikipedia.org)
  • FUS gene rearrangement has been implicated in the pathogenesis of myxoid liposarcoma, low-grade fibromyxoid sarcoma, Ewing sarcoma, and a wide range of other malignant and benign tumors (see FET protein family). (wikipedia.org)
  • Approximately 15% of ALS cases are inheritable, and mutations in the Fused in Sarcoma ( FUS ) gene contribute to approximately 5% of these cases, as well as about 2% of sporadic cases. (uky.edu)
  • The RNA sequence of the vaccine as well as the spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations. (shtfplan.com)
  • Fused in sarcoma (FUS) is a DNA/RNA binding protein that is dysfunctional in various malignant tumors. (biomedcentral.com)
  • Many SG proteins are affected by mutations causative of these conditions, including fused in sarcoma (FUS). (worktribe.com)
  • A neuropathological subtype of FTD, frontotemporal lobar degeneration (FTLD)-FET, is characterized by protein aggregates consisting of the RNA-binding protein fused in sarcoma (FUS). (ulaval.ca)
  • Immunohistochemical findings prompted us to sequence the fused in sarcoma (FUS) gene. (ox.ac.uk)
  • ¹⁵ Globally, the most common include expansions of chromosome 9 open reading frame 72 (C9orf72) and variants in superoxide dismutase 1 (SOD1), TANK1-binding kinase 1, fused in sarcoma (FUS), and TAR DNA-binding protein 43 (TDP-43). (aviadobio.com)
  • Among them, FUST-1, the homolog of FUS (fused in sarcoma), down-regulates both circRNA formation and exon skipping of the same pre-mRNA without affecting its cognate linear mRNA levels. (oist.jp)
  • Such FUS aggregates are a pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS). (wikipedia.org)
  • As a result, FUS protein and mRNA are trapped within cells and likely form clumps (aggregates), which have been found in nerve cells that control muscle movement (motor neurons) in some people with ALS. (medlineplus.gov)
  • It is unclear if protein aggregates cause the nerve cell death that leads to ALS. (medlineplus.gov)
  • [10] Furthermore, evidence has emerged that small, non-fibrillar protein aggregates known as oligomers are toxic to the cells of an affected organ, and that amyloidogenic proteins in their fibrillar form may be relatively benign. (wikipedia.org)
  • TDP-43 pathology includes cytoplasmic aggregates of the normally nuclear protein. (alzforum.org)
  • Different methodologies were used to examine whether these drugs can aid removal of FUS aggregates and decrease levels of mutant FUS protein. (edu.au)
  • The disease entities which are now considered subtypes of FTLD-FUS are atypical frontotemporal lobar degeneration with ubiquitinated inclusions (aFTLD-U), NIFID, and basophilic inclusion body disease (BIBD), which together with ALS-FUS comprise the FUS-proteopathies. (wikipedia.org)
  • For example, cystic fibrosis is caused by a defective cystic fibrosis transmembrane conductance regulator (CFTR) protein, [3] and in amyotrophic lateral sclerosis / frontotemporal lobar degeneration (FTLD), certain gene-regulating proteins inappropriately aggregate in the cytoplasm, and thus are unable to perform their normal tasks within the nucleus. (wikipedia.org)
  • The molecular genetic relationship with frontotemporal lobar degeneration with FUS pathology remains to be clarified. (ox.ac.uk)
  • Subsequently, FUS has also emerged as a significant disease protein in a subgroup of frontotemporal dementias (FTDs), previously characterized by immunoreactivity of the inclusion bodies for ubiquitin, but not for TDP-43 or tau with a proportion of the inclusions also containing alpha-internexin (α-internexin) in a further subgroup known as neuronal intermediate filament inclusion disease (NIFID). (wikipedia.org)
  • Phase transition also contributes to the formation of cytoplasmic inclusions found in the cell bodies of FUS ALS patients motor neurons. (uky.edu)
  • The nature of these inclusions has remained elusive, as the proteins localized to them have not been identified. (uky.edu)
  • Additionally, the functional consequence of the accumulation of cytoplasmic FUS inclusions has not been established, nor is it understood how they contribute to selective motor neuron death. (uky.edu)
  • We carried out two related, but independent studies to characterize the proteins that may be included in FUS-positive inclusions. (uky.edu)
  • Immunofluorescent staining of proteins interacting with mutant FUS were localized to cytoplasmic inclusions. (uky.edu)
  • In the second study, we developed a protocol to isolate dynamic FUS inclusions and employed LC MS/MS to identify all proteins associated with FUS inclusions. (uky.edu)
  • We identified a cohort of proteins involved in translation, splicing, and RNA export to be associated with the FUS inclusions. (uky.edu)
  • Many proteins found in pathological inclusions are known to undergo liquid-liquid phase separation, a reversible process of molecular self-assembly. (nih.gov)
  • The authors report that TDP-43 possesses a prion-like domain that allows it to bind polyglutamate inclusions, such as those found in Huntington disease. (alzforum.org)
  • Validation experiments for a mFA-specific protein, hnRNPA3, confirmed its RNA-dependent interaction with FUS and its sequestration into FUS inclusions in cultured cells and in a FUS transgenic mouse model. (worktribe.com)
  • Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. (ox.ac.uk)
  • BACKGROUND: Juvenile amyotrophic lateral sclerosis (ALS) with basophilic inclusions is a form of ALS characterized by protein deposits in motor neurons that are morphologically and tinctorially distinct from those of classic sporadic ALS. (ox.ac.uk)
  • METHODS: We identified neuropathologically 4 patients with juvenile ALS with basophilic inclusions and tested the hypothesis that specific RNA binding protein pathology may define this type of ALS. (ox.ac.uk)
  • Basophilic inclusions were strongly positive for FUS protein but negative for TAR DNA binding protein 43 (TDP-43). (ox.ac.uk)
  • CONCLUSION: Juvenile ALS with basophilic inclusions is a FUS proteinopathy and should be classified as ALS-FUS. (ox.ac.uk)
  • Although FUS/TLS is normally located predominantly in the nucleus, the pathogenic mutant forms of FUS/TLS traffic to, and form inclusions in, the cytoplasm of affected spinal motor neurons or glia. (cornell.edu)
  • FUS/TLS was independently identified as the hnRNP P2 protein, a subunit of a complex involved in the maturation of pre-mRNA. (wikipedia.org)
  • Additionally, FUS/TLS has been found to bind a relatively long region in the 3′ untranslated region (UTR) of the actin-stabilising protein Nd1-L mRNA, suggesting that rather than recognising specific short sequences, FUS/TLS interacts with multiple RNA-binding motifs or recognises secondary conformations. (wikipedia.org)
  • The FUS protein is also involved in processing molecules called messenger RNA (mRNA), which serve as the genetic blueprints for making proteins. (medlineplus.gov)
  • By cutting and rearranging mRNA molecules in different ways, the FUS protein controls the production of different versions of certain proteins. (medlineplus.gov)
  • Once the FUS protein processes the mRNA, it transports the mRNA out of the nucleus where it gets taken up by other cell structures to be further processed into a mature protein. (medlineplus.gov)
  • Most of these mutations change single protein building blocks in the FUS protein and often affect the region of the protein involved in DNA binding and mRNA processing. (medlineplus.gov)
  • He was one of the first researchers to discover ribosomal frameshifting as a gene expression mechanism in plant RNA viruses and to demonstrate recombination between transgene mRNA and genomic RNA of an infecting virus. (bio5.org)
  • This protein belongs to the FET family of RNA-binding proteins which have been implicated in cellular processes that include regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. (sitoolsbiotech.com)
  • Furthermore, we found that proteasome subunits and certain nucleocytoplasmic transport factors are depleted from mFAs, whereas translation elongation, mRNA surveillance and splicing factors as well as mitochondrial proteins are enriched in mFAs, as compared to SGs. (worktribe.com)
  • In recent years, nucleic acid therapy involving various types of ribonucleic acids (RNAs), including messenger RNA (mRNA), small interfering RNA (siRNA), and microRNA (miRNA), has rapidly emerged as a new cornerstone of modern medicine. (techadda2.com)
  • In the present context of successful mRNA drugs, the further synthesis of linear mRNA into circular RNA (circRNA) through end-to-end connections to enhance mRNA stability and prolong protein translation time has emerged as a new hot topic in the field of mRNA therapy. (techadda2.com)
  • Naturally occurring circular RNAs in organisms mostly arise from precursor mRNAs (pre-mRNA) through a process known as back-splicing. (techadda2.com)
  • We then examined the effects of a loss of FUS function on NCDN in neurons and found that depleting cells of FUS leads to a decrease in NCDN protein and mRNA levels. (ulaval.ca)
  • It also associates with the general transcriptional machinery and may influence transcription initiation and promoter selection by interacting with RNA polymerase II and the TFIID complex. (wikipedia.org)
  • Mutations in the FUS nuclear localization sequence impairs the poly (ADP-ribose) polymerase (PARP)-dependent DNA damage response. (wikipedia.org)
  • This reaction requires a DNA template, reaction buffer, and bacteriophage RNA polymerase. (techadda2.com)
  • Bacteriophage RNA polymerases are commonly derived from T7, SP6, or T3 phages, with T7 RNA polymerase being the more prevalent choice. (techadda2.com)
  • The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. (micrornaprofile.com)
  • The RNA-dependent RNA polymerase is a target of antiviral therapies. (micrornaprofile.com)
  • 2023) RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis. (ulelab.info)
  • In 2009 two separate research groups analysed 26 unrelated families who presented with a type6 ALS phenotype, and found 14 mutations in the FUS gene. (wikipedia.org)
  • At least 85 mutations in the FUS gene have been found to cause amyotrophic lateral sclerosis (ALS), a condition characterized by progressive muscle weakness, a loss of muscle mass, and an inability to control movement. (medlineplus.gov)
  • People with ALS caused by mutations in the FUS gene tend to develop the disease at a younger age and have a decreased life expectancy compared with individuals who have sporadic ALS or ALS caused by mutations in other genes. (medlineplus.gov)
  • Rarely, people with ALS caused by FUS gene mutations also develop a condition called frontotemporal dementia (FTD), which is a progressive brain disorder that affects personality, behavior, and language. (medlineplus.gov)
  • It is unclear why some people with FUS gene mutations develop FTD and others do not. (medlineplus.gov)
  • Specific mutations involving the FUS gene are involved in several types of cancer. (medlineplus.gov)
  • FUS gene mutations have also been found in myxoid liposarcomas, which occur in fatty tissues of the body, and in cancer of the blood-forming cells in the bone marrow called acute myeloid leukemia (AML). (medlineplus.gov)
  • ALS mutations in TLS/FUS disrupt target gene expression. (medlineplus.gov)
  • By contrast, in the case of TEM-1 beta-lactamase mutations, aggregation is linked to a decreased cell fitness due to inactivation of protein function. (frontiersin.org)
  • Protein domain analysis indicates that the carboxyl-terminus of FUS/TLS, where most of the ALS-associated mutations are clustered, is required but not sufficient for the toxicity of the protein. (cornell.edu)
  • To date, two-thirds of fALS are associated with mutations in any of more than 25 genes [ 3 , 4 , 5 ], encoding proteins involved in protein homeostasis, RNA metabolism, vesicular trafficking, and cytoskeletal organization. (en-journal.org)
  • The FUS protein is a nuclear DNA/RNA binding protein that regulates gene expression and that when mutations occur in this protein it can aggregate and contribute to MND pathology. (edu.au)
  • When two mutations (R446S and P447L), which are equivalent to natural mutations in the FUS nuclear localization signal (R524S and P525L) observed in amyotrophic lateral sclerosis, were introduced into FUST-1, both of the mutations dramatically down-regulated the formation of circRNAs. (oist.jp)
  • The ability to accurately detect nucleotide regions that differentially react with RNA structure probing reagents under diverse conditions, or due to the effect of mutations, is of great importance to researchers. (biomedcentral.com)
  • Moreover, a positive relationship was found between nuclear and cytoplasmic co-localization FUS and IL-13Rα2 expression. (biomedcentral.com)
  • In HGG, IL-13Rα2 combined with nuclear and cytoplasmic co-localization of FUS was associated with worse OS. (biomedcentral.com)
  • IL-13Rα2 expression was significantly associated with cytoplasmic distribution of FUS in human glioma samples and could be the independent prognostic factors for OS, while the prognostic value of its co-expression with cytoplasmic FUS in glioma need to be addressed in the future studies. (biomedcentral.com)
  • Formation of cytoplasmic RNA-protein structures called stress granules (SGs) is a highly conserved cellular response to stress. (worktribe.com)
  • Mutant FUS variants have high affinity to SGs and also spontaneously form de novo cytoplasmic RNA granules. (worktribe.com)
  • Results of our study support a pathogenic role for cytoplasmic FUS assemblies in ALS-FUS. (worktribe.com)
  • We examined the effects of NCDN haploinsufficiency on FUS and found that depleting primary cortical neurons of NCDN causes a reduction in the total number of FUS-positive cytoplasmic granules. (ulaval.ca)
  • Moreover, we provide evidence for a negative feedback loop of toxicity between NCDN and FUS, where loss of NCDN alters FUS cytoplasmic dynamics, which in turn has an impact on NCDN expression. (ulaval.ca)
  • Here we report a yeast model of human FUS/TLS expression that recapitulates multiple salient features of the pathology of the disease-causing mutant proteins, including nuclear to cytoplasmic translocation, inclusion formation, and cytotoxicity. (cornell.edu)
  • A genome-wide genetic screen using a yeast over-expression library identified five yeast DNA/RNA binding proteins, encoded by the yeast genes ECM32, NAM8, SBP1, SKO1, and VHR1, that rescue the toxicity of human FUS/TLS without changing its expression level, cytoplasmic translocation, or inclusion formation. (cornell.edu)
  • FUS performs a diverse set of cellular functions, including being a major regulator of RNA metabolism. (uky.edu)
  • To understand how protein synthesis is suppressed by mutant FUS mediated defects in RNA metabolism, we examined changes in a well conserved RNA turnover pathway namely: nonsense mediated decay (NMD). (uky.edu)
  • TDP-43 regulates RNA metabolism, trafficking, and localization of thousands of target genes. (nature.com)
  • 2022). Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation. (upenn.edu)
  • 2023) A computationally-enhanced hiCLIP atlas reveals Staufen1-RNA binding features and links 3' UTR structure to RNA metabolism. (ulelab.info)
  • Consistently, in vitro studies have shown that FUS/TLS binds RNA, single-stranded DNA and (with lower affinity) double-stranded DNA. (wikipedia.org)
  • In this first study, we utilized immunoprecipitation of wild-type and mutant FUS in the presence and absence of RNase, followed by LC MS/MS. The identified proteins represent those that directly or indirectly interact with FUS, with relatively high affinity that can be pulled down with immunoprecipitation. (uky.edu)
  • Because CaM can bind with high affinity to a relatively small alpha-helical region of many proteins, success in clearly defining the essential elements of CaM binding motifs seems feasible and should provide a means of identifying CaM binding proteins. (embl.de)
  • However, when the researchers performed the same experiments with the TDP-43 mutants Q331K and M337V, they found that much more FUS tagged along, suggesting the mutants have increased affinity for FUS, or a for complex that also contains FUS. (alzforum.org)
  • Here we used affinity purification to isolate mFAs and physiological SGs and compare their protein composition. (worktribe.com)
  • Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. (origene.com)
  • The interaction is most likely an early event" in disease, Ling speculated, leading up to later stages where TDP-43 and FUS, normally nuclear proteins, are mislocalized and aggregated in the cytoplasm. (alzforum.org)
  • These circular RNAs are distributed in the cytoplasm and exhibit half-lives ranging from 18.8-23.7 hours, significantly longer than their linear homologs which have half-lives of only 4.0-7.4 hours. (techadda2.com)
  • Granular and compact FUS deposits were identified in glia and neuronal cytoplasm and nuclei. (ox.ac.uk)
  • The function of FUS in the DNA damage response in neurons involves a direct interaction with histone deacetylase 1 (HDAC1). (wikipedia.org)
  • Their interaction with FUS varied greatly in their requirements for RNA. (uky.edu)
  • RNAct: Protein-RNA interaction predictions for model organisms with supporting experimental data. (tartaglialab.com)
  • Calmodulin (CaM) is recognized as a major calcium sensor and orchestrator of regulatory events through its interaction with a diverse group of cellular proteins. (embl.de)
  • Many investigations have focused on defining the region of interaction between CaM and its cellular targets and the action of CaM on target protein function. (embl.de)
  • Three recognition motifs for CaM interaction are discussed in the context of experimental investigations of a variety of CaM target proteins. (embl.de)
  • Researchers have long sought to connect TDP-43 and FUS in a common pathway leading to neurodegenerative disease, so Ling and colleagues pursued this particular interaction further. (alzforum.org)
  • Both have prion-like, protein-protein interaction domains, he noted, by which they could potentially join the same complex. (alzforum.org)
  • This impairment leads to neurodegeneration and FUS aggregate formation. (wikipedia.org)
  • Emerging evidence supports the hypothesis that aberrant phase separation behavior may serve as a trigger of protein aggregation in neurodegeneration, and efforts to understand and control the underlying mechanisms are underway. (nih.gov)
  • 2015. Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice . (cardiff.ac.uk)
  • FUS/TLS, EWS and TAF15 have a similar structure, characterised by an N-terminal QGSY-rich region, a highly conserved RNA recognition motif (RRM), multiple RGG repeats, which are extensively demethylated at arginine residues and a C-terminal zinc finger motif. (wikipedia.org)
  • TDP-43 is a highly conserved, ubiquitously expressed, multifunctional nucleic acid-binding protein composed of two RNA recognition motifs (RRM), nuclear localization (NLS) and export signals (NES), and a carboxy-terminal glycine rich region. (nature.com)
  • Protein translation assays using both N2A and ALS patient fibroblasts demonstrated suppression of protein biosynthesis in mutant FUS expressing cells. (uky.edu)
  • We found that NMD is hyperactivated in cells expressing mutant FUS, likely due to chronic suppression of protein translation shifting the pathways autoregulatory circuit to allow for hyperactivation. (uky.edu)
  • We concluded that mutant FUS suppresses protein biosynthesis and disrupts NMD regulation. (uky.edu)
  • Indeed, the network inference problem persists in systems biology, despite an abundance of regulatory evidence in the form of TF binding experiments, genetic screens for candidate nodes, and mutant expression profiling experiments. (biomedcentral.com)
  • Ling and colleagues wondered if the mutant proteins hang around in the cell longer than the wild-type does. (alzforum.org)
  • Mutant FUS-containing assemblies (mFAs), often called "pathological SGs", are proposed to play a role in ALS-FUS pathogenesis. (worktribe.com)
  • In conclusion, we show that SG-like structures formed by mutant FUS are structurally distinct from SGs, prone to persistence, likely cannot functionally replace SGs, and affect a spectrum of cellular pathways in stressed cells. (worktribe.com)
  • To assess the pathogenic effects of this variant, we have used patient-derived skin fibroblasts and motor neuron-specific overexpression of the RAPGEF2-E1357K mutant protein in Drosophila . (en-journal.org)
  • This project aimed to test the effect of treating transgenic zebrafish larvae expressing mutant FUS-R521C-GFP protein with drugs that induce the autophagy pathway. (edu.au)
  • 15:10 Professor Peter Giese, Do deficits in synaptic protein synthesis underlie pathology and memory loss in Alzheimer's disease? (ukdri.ac.uk)
  • FUS pathology. (uni-muenchen.de)
  • The goal of this study was to identify genetic variants contributing to FTLD-FET and to investigate their effects on FUS pathology. (ulaval.ca)
  • The name FUS refers to the fact that genetic recombination events result in fusion oncogene proteins (ONCOGENE PROTEINS, FUSION) that contain the N-terminal region of this protein. (bvsalud.org)
  • FUS/TLS is a nucleic acid binding protein that, when mutated, can cause a subset of familial amyotrophic lateral sclerosis (fALS). (cornell.edu)
  • FUS loss-of-function results in increased DNA damage in neurons. (wikipedia.org)
  • Ling plans to examine TDP-43 stability and protein-protein interactions in neurons and patient-derived cells. (alzforum.org)
  • It investigated the role of the RNA-binding protein FUS in the degeneration and death of motor neurons. (gatescambridge.org)
  • Normally the FUS protein exists in lipid droplets, but in patients with inherited motor neurone disease it forms abnormal masses which are detrimental to neurons. (gatescambridge.org)
  • Recently, new evidence suggests that PIWI proteins and piRNAs also play important roles in various somatic tissues, including neurons. (molcells.org)
  • Through the large-scale isolation of neurons from the first larval stage of Caenorhabditis elegans, C. elegans neuronal circRNA profile was analyzed for the first time by RNA sequencing of the whole-transcriptome. (oist.jp)
  • This gene encodes a multifunctional protein component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex. (sitoolsbiotech.com)
  • TDP-43 is known to modify mRNAs, so it was no surprise to see components of the heterogenous nuclear ribonuclear (hnRNP) protein complex, as well as other RNA-binding proteins. (alzforum.org)
  • however, using in vitro selection (SELEX), a common GGUG motif has been identified in approximately half of the RNA sequences bound by FUS/TLS. (wikipedia.org)
  • FUS/TLS has also been proposed to bind human telomeric RNA (UUAGGG)4 and single-stranded human telomeric DNA in vitro. (wikipedia.org)
  • FUS undergoes liquid- liquid phase transition in vitro , allowing for its participation in stress granules and RNA transport granules. (uky.edu)
  • PKC phosphorylation of these proteins also inhibits their binding to RNA in vitro. (embl.de)
  • Although the majority of natural circular RNAs are non-coding RNAs, meaning they cannot be translated into proteins, research has shown that artificially synthesized circular RNAs with internal ribosome entry site (IRES) sequences can be translated both in vivo and in vitro. (techadda2.com)
  • Enzymatic ligation for circular RNA synthesis is typically achieved through in vitro transcription (IVT) reactions. (techadda2.com)
  • Recently, FUS/TLS was also shown to repress the transcription of RNAP III genes and to co-immunoprecipitate with TBP and the TFIIIB complex. (wikipedia.org)
  • The FUS protein attaches (binds) to DNA and regulates an activity called transcription, which is the first step in the production of proteins from genes. (medlineplus.gov)
  • The identified non-ribosomal FUS interacting partners. (uky.edu)
  • Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. (micrornaprofile.com)
  • A modified version of the IQ motif as a consensus for Ca2+-independent binding and two related motifs for Ca2+-dependent binding, termed 18-14 and 1-5-10 based on the position of conserved hydrophobic residues, are proposed. (embl.de)
  • Although considerable sequence diversity is observed among the different binding regions, these three classes of recognition motifs exist for many of the known CaM binding proteins. (embl.de)
  • A wide variety of interacting proteins were identified and they are involved in a multitude of pathways including: chromosomal organization, transcription, RNA splicing, RNA transport, localized translation, and stress response. (uky.edu)
  • Further pathway and disease association analysis suggested that proteins associated with translation and RNA quality control pathways may be the most significant. (uky.edu)
  • These data suggest that PKC may regulate interactions of EWS and other RNA-binding proteins with their RNA targets and that IQ domains may provide a regulatory link between Ca2+ signal transduction pathways and RNA processing. (embl.de)
  • In addition, Ling and colleagues' paper describes one possible way TDP-43 and FUS pathways could intersect. (alzforum.org)
  • A full understanding of neuronal PIWI-piRNA pathways will ultimately provide novel insights into small RNA biology and could potentially provide precise targets for therapeutic applications. (molcells.org)
  • The RNA sequence in the vaccine [3] contains sequences believed to induce TDP-43 and FUS to aggregate in their prion-based conformation leading to the development of common neurodegerative diseases. (eatingtoascend.com)
  • Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) share overlapping genetic causes and disease symptoms, and are linked neuropathologically by the RNA binding protein TDP-43 (TAR DNA binding protein-43 kDa). (nature.com)
  • TDP-43 is intimately linked with amyotrophic lateral sclerosis, but the mystery remains as to what the protein is normally meant to do, and what goes wrong when it mutates. (alzforum.org)
  • A wealth of knowledge has been published on a class of RNA binding proteins shown to participating in causing a number of neurological diseases including Alzheimer's disease and ALS (Amyotrophic Lateral Sclerosis). (eatingtoascend.com)
  • For example, proteins that are normally unfolded or relatively unstable as monomers (that is, as single, unbound protein molecules) are more likely to misfold into an abnormal conformation. (wikipedia.org)
  • G-quadruplexes are secondary semi-stable folded structures found in our DNA and RNA which tend to assemble around guanine-rich sequences in the presence of cation molecules like potassium. (anti-agingfirewalls.com)
  • IVT reactions enable the cost-effective production of longer circular RNA molecules, making enzymatic synthesis the current mainstream method for circular RNA synthesis. (techadda2.com)
  • Circular RNAs (circRNAs) are regulatory molecules that show diverse functions. (oist.jp)
  • FUS/TLS is a member of the FET protein family that also includes the EWS protein, the TATA-binding protein TBP-associated factor TAFII68/TAF15, and the Drosophila cabeza/SARF protein. (wikipedia.org)
  • Silencing of the Drosophila hnRNPA3 ortholog was deleterious and potentiated human FUS toxicity in the retina of transgenic flies. (worktribe.com)
  • The PIWI protein was initially described in Drosophila , and its name, P-element-induced wimpy testis (PIWI), was assigned as a result of the destructive effect on testis development observed in PIWI knockout ( Lin and Spradling, 1997 ). (molcells.org)
  • High-Resolution RNA Maps Suggest Common Principles of Splicing and Polyadenylation Regulation by TDP-43 , Cell Reports. (ulelab.info)
  • The FUS protein also helps repair errors in DNA, which prevents cells from accumulating genetic damage. (medlineplus.gov)
  • The genetic changes associated with these cancers are rearrangements (translocations) of genetic material between chromosome 16 (where the FUS gene is located) and other chromosomes. (medlineplus.gov)
  • In an important model of premature aging, Werner's Syndrome, the genetic problem seems to be lack of a helicase protein that can unwind G-quadruplexes. (anti-agingfirewalls.com)
  • Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. (micrornaprofile.com)
  • SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. (micrornaprofile.com)
  • We concluded that mis-localization of these proteins potentially lead to their dysregulation or loss of function, thus contributing to FUS pathogenesis. (uky.edu)
  • In simple terms, circular RNA is a closed single-stranded RNA molecule formed through covalent linkage at its ends. (techadda2.com)
  • Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). (micrornaprofile.com)
  • The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. (shtfplan.com)
  • Se han encontrado estas proteínas de fusión en el liposarcoma mixoide (LIPOSARCOMA MIXOIDE) y en la leucemia mieloide aguda. (bvsalud.org)
  • These fusion proteins have been found in myxoid liposarcoma (LIPOSARCOMA, MYXOID) and acute myeloid leukemia. (bvsalud.org)
  • A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics. (ulaval.ca)
  • Our study identifies the NCDN protein as a likely contributor of FTLD-FET pathophysiology. (ulaval.ca)
  • His recent collaboration with Dr. Martha Hawes has led to the discovery that extracellular DNA, secreted DNases, and proteins are important immunity and pathogenicity factors in the plant-microbe interactions in the rhizosphere. (bio5.org)
  • Two recent papers address these questions, focusing on TDP-43's stability and protein-protein interactions. (alzforum.org)
  • We found that proteins within mFAs form significantly more physical interactions than those in SGs however mFAs fail to recruit many factors involved in signal transduction. (worktribe.com)
  • The majority of proteins function as monodispersed ordered species dissolved in intra- or extra-cellular aqueous fluids. (frontiersin.org)
  • Dr. Xiong is a 2012 winner of the Bill Gates and Melinda Foundation Grand Challenges Explorations in Global Health, and has more than 20 years of research experience on RNA viruses of important crops and native plant species. (bio5.org)
  • PIWI Argonaute proteins and Piwi-interacting RNAs (piRNAs) are expressed in all animal species and play a critical role in cellular defense by inhibiting the activation of transposable elements in the germline. (molcells.org)
  • Furthermore, hUPF1, a human homologue of ECM32, also rescues the toxicity of FUS/TLS in this model, validating the yeast model and implicating a possible insufficiency in RNA processing or the RNA quality control machinery in the mechanism of FUS/TLS mediated toxicity. (cornell.edu)
  • Examination of the effect of FUS/TLS expression on the decay of selected mRNAs in yeast indicates that the nonsense-mediated decay pathway is probably not the major determinant of either toxicity or suppression. (cornell.edu)
  • Julie is also working on a technique using a bright fluorescent protein, Venus, to monitor protein synthesis in a cell. (gatescambridge.org)
  • Currently, the chemical synthesis of circular RNA primarily relies on phosphoramidite chemistry and solid-phase synthesis, using naturally occurring nucleoside triphosphate derivatives as building blocks. (techadda2.com)
  • However, the current chemical synthesis technology for circular RNA can only generate circular RNAs with lengths of fewer than 70-80 nucleotides (nt). (techadda2.com)
  • piRNA is the most diverse class of regulatory RNAs in general. (molcells.org)
  • The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit. (eatingtoascend.com)
  • The paper goes on to state that "The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer's disease, and other neurological degenerative diseases. (shtfplan.com)
  • We present one use case with a corpus of ~34 million text documents downloaded online to provide an example of elucidating the role of mitochondrial proteins in distinct cardiovascular disease phenotypes using this method. (bvsalud.org)
  • 2023). Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains. (upenn.edu)
  • There are 165951 IQ domains in 60575 proteins in SMART's nrdb database. (embl.de)
  • A) Domains of the PIWI protein. (molcells.org)
  • CHOP) conferring a strong transcriptional activation domain onto the fusion proteins. (wikipedia.org)
  • In these instances, the promoter and N-terminal part of FUS/TLS is translocated to the C-terminal domain of various DNA-binding transcription factors (e.g. (wikipedia.org)
  • In addition recognition sites for the transcription factors AP2, GCF, Sp1 have been identified in FUS. (wikipedia.org)
  • Beyond nucleic acid binding, FUS/TLS was also found to associate with both general and more specialized protein factors to influence the initiation of transcription. (wikipedia.org)
  • Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. (micrornaprofile.com)
  • Short calmodulin-binding motif containing conserved Ile and Gln residues. (embl.de)
  • Calmodulin-binding motif. (embl.de)
  • 2023). Genome-wide RNA binding analysis of C9orf72 poly(PR) dipeptides. (upenn.edu)
  • Most notably, FUS interacted with hnRNPA1 and Matrin-3, proteins also known to cause familial ALS. (uky.edu)
  • These proteins include FUS, TDP-43 and hnRNPA1, A2 and A3. (uni-muenchen.de)
  • Acts as a 'third messenger' substrate of protein kinase C-mediated molecular cascades during synaptic development and remodeling. (embl.de)
  • The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. (embl.de)
  • Here we report that EWS, a nuclear RNA-binding prooncoprotein, contains an IQ domain, is phosphorylated by protein kinase C, and interacts with calmodulin. (embl.de)
  • Micrograph of a section of the cerebral cortex from a person with Alzheimer's disease , immunostained with an antibody to amyloid beta (brown), a protein fragment that accumulates in amyloid plaques and cerebral amyloid angiopathy . (wikipedia.org)
  • Human IgG antibody Laboratories manufactures the pan sars rna test reagents distributed by Genprice. (micrornaprofile.com)
  • Indeed, FUS/TLS interacts with several nuclear receptors. (wikipedia.org)
  • [20] They have been most thoroughly studied with regard to prion disease , and are referred to as protein strains . (wikipedia.org)
  • The article, titled "COVID-19 RNA Based Vaccines and the Risk of Prion Disease," was published in January of 2021 and has been studiously ignored by the mainstream media, which has focused its efforts on encouraging individuals to take the jab. (shtfplan.com)
  • The FUS gene provides instructions for making a protein that is found within the cell nucleus in most tissues and is involved in many of the steps of protein production. (medlineplus.gov)
  • In our lab we are specifically interested in RNA binding proteins, which are cleared from the nucleus and deposited in the cytsosol. (uni-muenchen.de)
  • At week 24, those receiving tofersen showed a reduction in concentrations of toxic SOD1 protein and markers of neuronal injury. (cdc.gov)
  • T4 Dnl and T4 Rnl 1 are suitable for circularizing RNA without complex secondary structures, while T4 Rnl 2 is more appropriate for linear RNA precursors with double-stranded adapter regions. (techadda2.com)
  • Interestingly, PKC phosphorylation of EWS inhibits its binding to RNA homopolymers, and conversely, RNA binding to EWS interferes with PKC phosphorylation. (embl.de)
  • Here, we analysed two deep mutational scanning experiments to investigate the role of protein aggregation in molecular evolution. (frontiersin.org)
  • Here, we set to clarify this complex matter and question of whether aggregation is an important constraint in protein evolution that can be the discriminant between beneficial and detrimental situations by considering two cases: we studied molecular evolution of proteins in an endogenous vs. exogenous host. (frontiersin.org)

No images available that match "rna binding protein fus"